James Holland, an early proponent of using combination chemotherapy to combat aggressive cancers that were often otherwise untreatable in the 1960s and 70s, has passed away at 92. Holland's research, which focused on using chemotherapy to treat childhood acute lymphoblastic leukemia, earned him a 1972 Albert Lasker Clinical Medical Research Award.

 

Read the obituary

"The most important person in the cancer revolution...is Mary Lasker." In a video on the legacy of the Lasker Foundation, James Holland discusses Mary Lasker's role in galvanizing federal funding for cancer research.